The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

CDDF Funding


in line with European law, CDDF Funding relies on profit raised from conferencesdonations and grants as well as membership fees from corporations whose work is aligned with our mission.

CDDF funding is managed according to strict rules for non-profit organisations allowing it to act as an independent entity.

To support CDDF administration and activities, we request annual unrestricted grants of 40.000 EUR from industry partners (or 7.000 EUR from SMEs*).

This fee provides access to the industry partner group where companies converge to discuss industry perspectives on the challenges to be addressed in cancer drug development; and to CDDF workshops (up to three representatives per company).

We invite you to help us to continue working toward effective cancer treatment and delivery by supporting the CDDF.


If you wish to support our mission, please contact our office at

* A pharmaceutical partner is considered to be an SME if it has no drug on the market or if it meets the definition of the European Commission for an SME: 


Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70